Meeting
2013 ASCO Annual Meeting
A comparison of immunohistochemistry (IHC) and dual-color silver in situ hybridization (SISH) with a novel method combining both gene and protein platforms on a unique slide for testing the HER2 in gastric carcinoma.
Authors
Dominique Werner
Krankenhaus Nordwest, UCT University Cancer Center, Frankfurt, Germany
Dominique Werner , Achim Battmann , Kristina Steinmetz , Tobin Jones , Michele Martinez , Tiffany Lamb , Salah-Eddin Al-Batran
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Citation
J Clin Oncol 31, 2013 (suppl; abstr 4100)
DOI
10.1200/jco.2013.31.15_suppl.4100
Abstract #
4100
Poster Bd #
23F
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Systematic literature review and testing of HER2 status in urothelial carcinoma (UC).
First Author: Vadim S Koshkin
Poster
2014 Gastrointestinal Cancers Symposium
A novel method combining gene and protein platforms on one slide for the detection of HER2 in gastric cancer: Final results.
First Author: Dominique Werner
Poster
2023 ASCO Gastrointestinal Cancers Symposium
The HORIZON III retrospective exploratory analysis: HER2 expression amplification in colorectal cancer.
First Author: Fabiola Cecchi
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A randomized phase 2 study of trastuzumab and pertuzumab (TP) compared to cetuximab and irinotecan (CETIRI) in advanced/metastatic colorectal cancer (mCRC) with HER2 amplification: SWOG S1613.
First Author: Kanwal Pratap Singh Raghav